中国·太阳成集团tyc122cc(股份)有限公司-搜狗百科

Company News

LifeTech Scientific Corporation (1302.HK) Announced 2020 Annual Results

The leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases —LifeTech Scientific Corporation (the “Company”) and its subsidiaries (the “Group”) announced the audited consolidated results for the year ended 31 December 2020 (the “Reporting Period”).

2021 / 03 / 30
LifeTech Scientific (1302.HK) Announced 2020 Interim Results

LifeTech Scientific Corporation (the “Company”) and its subsidiaries (the “Group”) announced the unaudited consolidated results for the six months ended 30 June 2020 (the “Reporting Period”)

2020 / 08 / 28
LifeTech Scientific (1302.HK) Announced 2019 Annual Results

30th March, 2020,LifeTech Scientific Corporation (the “Company”) and its subsidiaries (the “Group”) announced the audited consolidated results for the year ended 31 December 2019 (the “Reporting Period”)

2020 / 03 / 30
Lifetech Publishes Interim Results 2018

Aug. 27, 2018-Hong Kong The minimally invasive cardiovascular interventional devices supplier Lifetech (the Company) and its subsidiaries (the Group) published their comprehensive results for the six months ending as at Jun. 30, 2018 (in the reporting period).

2018 / 08 / 27
LifeTech Announces Its Results for 2017

On March 28, 2018 in Hong Kong, LifeTech, a leading supplier of minimally invasive cardiovascular interventional devices announced its audited overall results for the year ended December 31, 2017.

2018 / 03 / 28
LifeTech Announces 2017 Interim Results

LifeTech Scientific Corporation, the leading supplier of minimally invasive interventional medical devices to treat cardiovascular diseases and its subsidiaries announces its comprehensive financial results as of June 30, 2017 .

2017 / 08 / 25
LifeTech announced the launch of its global post-market surveillance study for LAmbre ™ LAA Closure System

On June 30, at the Congenital and Structural Intervention Congress (CSI) 2017 in Frankfurt, LifeTech Scientific Corporation (Stock Code: 1302.HK) announced the launch of a 3-year global post-market surveillance (PMS) study for the LAmbreTM Left Atrial Appendage (LAA) Closure System. The study planned to enroll more than 500 patients from about 30 clinical centers in Europe, Asia and South America.

2017 / 07 / 03
LifeTech Announces 2016 Annual Results

Domestic Market Consolidation and Global Channel Expansion,Diversified Innovative Portfolio Promoted Sustainable Development,Steady Growth of Revenue and Significant Rise of Profitability.

2017 / 03 / 25
LifeTech Scientific Corporation Announces 2016 Interim Results

LifeTech Scientific Corporation, the world’s leading supplier of minimally invasive interventional medical devices designed for cardiovascular and peripheral vascular diseases and its subsidiaries announces its comprehensive financial results as of June 30, 2016 .

2016 / 08 / 26
Lifetech Scientific Corporation release 2015 annual results-press release

Global Channel Expansion, Stable Growth of Domestic Market Sales,Diversified Product Portfolio and Innovation Promote Sustainable Development,Steady Growth of Revenue and Significant Rise of Profitability.

2016 / 03 / 29